HealthieOne lead scientist Dr. Anne Le, during her tenure at Johns Hopkins Medicine, discovered that the neurotransmitter N-acetyl-aspartyl-glutamate (NAAG) plays a crucial role in cancer progression and spread. Her research revealed that NAAG is significantly more abundant in aggressive, higher-grade cancers and serves as an important glutamate reservoir that cancer cells use for survival and growth. Dr. Le's team found that NAAG levels in blood plasma correlate directly with tumor growth rates, making it a potential prognostic marker for noninvasive monitoring of cancer progression. This pioneering research not only identified a new therapeutic target for cancer treatment but also demonstrated Dr. Le's exceptional expertise in metabolomics and cancer metabolism that now drives HealthieOne's innovative approach to health monitoring.